BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26478200)

  • 1. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants.
    Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
    Vaccine; 2015 Nov; 33(48):6793-9. PubMed ID: 26478200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.
    Dangor Z; Kwatra G; Izu A; Lala SG; Madhi SA
    Expert Rev Vaccines; 2015 Jan; 14(1):135-49. PubMed ID: 25242617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections.
    Dangor Z; Lala SG; Kwatra G; Madhi SA
    Curr Opin Infect Dis; 2016 Jun; 29(3):262-7. PubMed ID: 26926474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study.
    Madhi SA; Izu A; Kwatra G; Jones S; Dangor Z; Wadula J; Moultrie A; Adam Y; Pu W; Henry O; Briner C; Cutland CL
    Clin Infect Dis; 2021 Sep; 73(5):e1170-e1180. PubMed ID: 33341870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
    Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
    Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B Streptococcal disease.
    Dangor Z; Kwatra G; Izu A; Khan M; Lala SG; Madhi SA
    Vaccine; 2021 Nov; 39(47):6813-6816. PubMed ID: 34688499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women.
    Dangor Z; Kwatra G; Izu A; Adrian P; van Niekerk N; Cutland CL; Adam Y; Velaphi S; Lala SG; Madhi SA
    J Infect Dis; 2015 Aug; 212(3):453-62. PubMed ID: 25651843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Breast Milk Group B Streptococcal Capsular Antibody Levels and Late-onset Disease in Young Infants.
    Dangor Z; Khan M; Kwatra G; Izu A; Nakwa F; Ramdin T; Fredericks J; Lala SG; Madhi SA
    Clin Infect Dis; 2020 Mar; 70(6):1110-1114. PubMed ID: 31056692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
    Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
    Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.
    Lin FY; Philips JB; Azimi PH; Weisman LE; Clark P; Rhoads GG; Regan J; Concepcion NF; Frasch CE; Troendle J; Brenner RA; Gray BM; Bhushan R; Fitzgerald G; Moyer P; Clemens JD
    J Infect Dis; 2001 Oct; 184(8):1022-8. PubMed ID: 11574917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants.
    Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
    Expert Rev Vaccines; 2015; 14(12):1651-60. PubMed ID: 26364978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns.
    Suara RO; Adegbola RA; Mulholland EK; Greenwood BM; Baker CJ
    J Natl Med Assoc; 1998 Feb; 90(2):109-14. PubMed ID: 9510625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
    Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
    J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Opsonophagocytic Antibodies against Serotype Ia, Ib, II, III, and V Group B Streptococcus among Korean Population.
    Lee JH; Kim HW; Kim KH
    J Korean Med Sci; 2018 Apr; 33(16):e127. PubMed ID: 29651820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines.
    Dzanibe S; Madhi SA
    Expert Rev Vaccines; 2018 Jul; 17(7):635-651. PubMed ID: 29961350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of type-specific group B streptococcal antibody in pregnant women.
    Vogel LC; Boyer KM; Gadzala CA; Gotoff SP
    J Pediatr; 1980 Jun; 96(6):1047-51. PubMed ID: 6989972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development.
    Dangor Z; Cutland CL; Izu A; Kwatra G; Trenor S; Lala SG; Madhi SA
    PLoS One; 2016; 11(12):e0169101. PubMed ID: 28036363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.